Literature DB >> 10672891

Iodine supplementation: benefits outweigh risks.

F Delange1, P Lecomte.   

Abstract

In 1990, iodine deficiency affected almost one-third of the world population and was the greatest single cause of preventable brain damage and mental retardation. Following a resolution adopted by the World Summit for Children in 1990. major programmes of iodine supplementation were implemented by the governments of the affected countries with the support of major donors. Iodisation of salt was recognised as the method of choice. Nine years later, by April 1999, 75% of the affected countries had legislation on salt iodisation and 68% of the affected populations had access to iodised salt. The prevalence of iodine deficiency disorders decreased drastically in most countries and the deficiency disappeared completely in some such as Peru. This result constitutes a public heath success unprecedented with a non-infectious disease. However, occasional adverse effects occurred. The principle effect is iodine-induced hyperthyroidism which occurs essentially in older people with autonomous nodular goitres, especially following iodine intake that is too rapid and of too massive an increment. The incidence of the disorder is usually low and reverts spontaneously to the background rate of hyperthyroidism or even below this rate after 1 to 10 years of iodine supplementation. The possible occurrence of iodine-induced thyroiditis in susceptible individuals has not been clearly demonstrated by large epidemiological surveys. Iodine supplementation is followed by an increased prevalence of occult papillary carcinoma of the thyroid discovered at autopsy but the prognosis of thyroid cancer is improved due to a shift towards differentiated forms of thyroid cancer that are diagnosed at earlier stages. Iodine-induced hyperthyroidism and other adverse effects can be almost entirely avoided by adequate and sustained quality control and monitoring of iodine supplementation which should also confirm adequate iodine intake. Available evidence clearly confirms that the benefits of correcting iodine deficiency far outweigh the risks of iodine supplementation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672891     DOI: 10.2165/00002018-200022020-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  36 in total

1.  Environmental factors affecting autoimmune thyroid disease.

Authors:  M Safran; T L Paul; E Roti; L E Braverman
Journal:  Endocrinol Metab Clin North Am       Date:  1987-06       Impact factor: 4.741

2.  Endemic goiter in Greece: metabolic studies.

Authors:  B Malamos; K Miras; D A Koutras; P Kostamis; D Binopoulos; J Mantzos; G Levis; G Rigopoulos; N Zerefos; C N Tassopoulos
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

3.  Increase in thyrotoxicosis in endemic goitre area after iodation of bread.

Authors:  R J Connolly; G I Vidor; J C Stewart
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

Review 4.  Iodine-induced hyperthyroidism: occurrence and epidemiology.

Authors:  J B Stanbury; A E Ermans; P Bourdoux; C Todd; E Oken; R Tonglet; G Vidor; L E Braverman; G Medeiros-Neto
Journal:  Thyroid       Date:  1998-01       Impact factor: 6.568

5.  The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey.

Authors:  F Aghini-Lombardi; L Antonangeli; E Martino; P Vitti; D Maccherini; F Leoli; T Rago; L Grasso; R Valeriano; A Balestrieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

6.  Earliest prevention of endemic goiter by iodine supplementation during pregnancy.

Authors:  K P Liesenkötter; W Göpel; U Bogner; B Stach; A Grüters
Journal:  Eur J Endocrinol       Date:  1996-04       Impact factor: 6.664

7.  Thyroid cell injury is an initial event in the induction of autoimmune thyroiditis by iodine in obese strain chickens.

Authors:  N Bagchi; T R Brown; R S Sundick
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

8.  Thyroid hormone and immunological studies in endemic goiter.

Authors:  M A Boukis; D A Koutras; A Souvatzoglou; A Evangelopoulou; M Vrontakis; S D Moulopoulos
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

9.  Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis.

Authors:  H R Harach; D A Escalante; A Onativia; J Lederer Outes; E Saravia Day; E D Williams
Journal:  Acta Endocrinol (Copenh)       Date:  1985-01

10.  Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency.

Authors:  B L Baltisberger; C E Minder; H Bürgi
Journal:  Eur J Endocrinol       Date:  1995-05       Impact factor: 6.664

View more
  11 in total

1.  Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).

Authors:  F Soriguer; P Santiago; L Vila; J M Arena; E Delgado; F Díaz Cadórniga; S Donnay; M Fernández Soto; S González-Romero; P Martul; M Puig Domingo; S Ares; F Escobar del Rey; G Morreale de Escobar
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

Review 2.  Thyroid cancer gender disparity.

Authors:  Reza Rahbari; Lisa Zhang; Electron Kebebew
Journal:  Future Oncol       Date:  2010-11       Impact factor: 3.404

3.  The Impact of Iodine Exposure in Excess on Hormonal Aspects and Hemato-Biochemical Profile in Rats.

Authors:  Hager Tarek H Ismail
Journal:  Biol Trace Elem Res       Date:  2021-03-30       Impact factor: 3.738

4.  International patterns and trends in thyroid cancer incidence, 1973-2002.

Authors:  Briseis A Kilfoy; Tongzhang Zheng; Theodore R Holford; Xuesong Han; Mary H Ward; Andreas Sjodin; Yaqun Zhang; Yana Bai; Cairong Zhu; Grace L Guo; Nathaniel Rothman; Yawei Zhang
Journal:  Cancer Causes Control       Date:  2008-11-19       Impact factor: 2.506

5.  Influence of dietary iodine on the iodine content of pork and the distribution of the trace element in the body.

Authors:  Katrin Franke; Friedrich Schöne; Andreas Berk; Matthias Leiterer; Gerhard Flachowsky
Journal:  Eur J Nutr       Date:  2008-01-14       Impact factor: 5.614

6.  Can we still consider thyroid hyperfunction a protective condition for the onset of thyroid cancer?

Authors:  Elena Bonati; Stefania Bettoni; Tommaso Loderer; Paolo Del Rio
Journal:  Gland Surg       Date:  2021-04

7.  Metabolic engineering of the iodine content in Arabidopsis.

Authors:  Martina Landini; Silvia Gonzali; Claudia Kiferle; Massimo Tonacchera; Patrizia Agretti; Antonio Dimida; Paolo Vitti; Amedeo Alpi; Aldo Pinchera; Pierdomenico Perata
Journal:  Sci Rep       Date:  2012-03-27       Impact factor: 4.379

8.  A shift to more targeted thyroidectomies increased the detection of thyroid cancer and in particular low-risk papillary tumors in Southwestern Greece the decade 2007 to 2016.

Authors:  Georgios K Markantes; Stylianos Tsochatzis; Konstantinos Panagopoulos; Maria Melachrinou; Venetsana E Kyriazopoulou; Kostas B Markou; Marina A Michalaki
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-11-24

Review 9.  Thyroid Carcinoma: Do We Need to Treat Men and Women Differently?

Authors:  Kerstin Lorenz; Rick Schneider; Malik Elwerr
Journal:  Visc Med       Date:  2020-01-14

10.  Iodine deficiency disorders (IDD) control in India.

Authors:  Chandrakant S Pandav; Kapil Yadav; Rahul Srivastava; Rijuta Pandav; M G Karmarkar
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.